252 related articles for article (PubMed ID: 18688909)
1. Musculoskeletal manifestations and rheumatic symptoms in patients with cystic fibrosis (CF) no observations of CF-specific arthropathy.
Koch AK; Brömme S; Wollschläger B; Horneff G; Keyszer G
J Rheumatol; 2008 Sep; 35(9):1882-91. PubMed ID: 18688909
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.
Skov M; McKay K; Koch C; Cooper PJ
Respir Med; 2005 Jul; 99(7):887-93. PubMed ID: 15939251
[TBL] [Abstract][Full Text] [Related]
3. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
[TBL] [Abstract][Full Text] [Related]
4. Serologic diagnosis of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis through the detection of immunoglobulin G to Aspergillus fumigatus.
Barton RC; Hobson RP; Denton M; Peckham D; Brownlee K; Conway S; Kerr MA
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):287-91. PubMed ID: 18947811
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic cleavage of the long pentraxin PTX3 in the airways of cystic fibrosis patients.
Hamon Y; Jaillon S; Person C; Giniès JL; Garo E; Bottazzi B; Ghamrawi S; Urban T; Subra JF; Bouchara JP; Mantovani A; Jeannin P; Delneste Y
Innate Immun; 2013 Dec; 19(6):611-22. PubMed ID: 23475792
[TBL] [Abstract][Full Text] [Related]
6. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis.
Kraemer R; Deloséa N; Ballinari P; Gallati S; Crameri R
Am J Respir Crit Care Med; 2006 Dec; 174(11):1211-20. PubMed ID: 16959918
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
Pressler T; Karpati F; Granström M; Knudsen PK; Lindblad A; Hjelte L; Olesen HV; Meyer P; Høiby N;
J Cyst Fibros; 2009 Jan; 8(1):37-42. PubMed ID: 18835753
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of cystic fibrosis presenting with or without meconium ileus: a matched cohort study.
Munck A; Gérardin M; Alberti C; Ajzenman C; Lebourgeois M; Aigrain Y; Navarro J
J Pediatr Surg; 2006 Sep; 41(9):1556-60. PubMed ID: 16952591
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis.
Gronowitz E; Lorentzon M; Ohlsson C; Mellström D; Strandvik B
Br J Nutr; 2008 Jan; 99(1):160-7. PubMed ID: 17697399
[TBL] [Abstract][Full Text] [Related]
11. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
[TBL] [Abstract][Full Text] [Related]
13. Serum antibodies to Aspergillus fumigatus in patients with rheumatic diseases.
Schønheyder H; Andersen I; Andersen P
Sabouraudia; 1983 Jun; 21(2):149-57. PubMed ID: 6348977
[TBL] [Abstract][Full Text] [Related]
14. Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation.
Van Biervliet S; Van Biervliet JP; Vande Velde S; Robberecht E
Biol Trace Elem Res; 2007 Oct; 119(1):19-26. PubMed ID: 17914215
[TBL] [Abstract][Full Text] [Related]
15. Bone mass density and associated factors in cystic fibrosis patients of young age.
Douros K; Loukou I; Nicolaidou P; Tzonou A; Doudounakis S
J Paediatr Child Health; 2008 Dec; 44(12):681-5. PubMed ID: 19077069
[TBL] [Abstract][Full Text] [Related]
16. Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA.
Casaulta C; Flückiger S; Crameri R; Blaser K; Schoeni MH
Pediatr Allergy Immunol; 2005 May; 16(3):217-25. PubMed ID: 15853950
[TBL] [Abstract][Full Text] [Related]
17. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation.
Bonvillain RW; Valentine VG; Lombard G; LaPlace S; Dhillon G; Wang G
J Heart Lung Transplant; 2007 Sep; 26(9):890-7. PubMed ID: 17845927
[TBL] [Abstract][Full Text] [Related]
18. Exhaled 8-isoprostane and prostaglandin E(2) in patients with stable and unstable cystic fibrosis.
Lucidi V; Ciabattoni G; Bella S; Barnes PJ; Montuschi P
Free Radic Biol Med; 2008 Sep; 45(6):913-9. PubMed ID: 18634869
[TBL] [Abstract][Full Text] [Related]
19. [MRI-based flow measurements in the main pulmonary artery to detect pulmonary arterial hypertension in patients with cystic fibrosis].
Wolf T; Anjorin A; Posselt H; Smaczny C; Vogl TJ; Abolmaali N
Rofo; 2009 Feb; 181(2):139-46. PubMed ID: 19101881
[TBL] [Abstract][Full Text] [Related]
20. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients.
Nilsson E; Larsson A; Olesen HV; Wejåker PE; Kollberg H
Pediatr Pulmonol; 2008 Sep; 43(9):892-9. PubMed ID: 18680179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
